Senesco Technologies, Inc. Opens Two New Clinical Trial Sites And Initiates Treatment Of The First Patient In South Africa

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTCQB:SNTI) reported the opening of two new sites in the Republic of South Africa at Pretoria East Hospital and Groote Schuur Hospital in Cape Town. Treatment of the first patient in South Africa has been initiated in Senesco’s Phase 1b/2a clinical study of its product candidate, SNS01-T.

Help employers find you! Check out all the jobs and post your resume.